Patents, Convenience, & the Future of Cancer Care

Every penny spent sustaining ultra-high-priced branded therapy is a penny not spent elsewhere in the health system—on earlier diagnosis, surgery, radiotherapy capacity, nursing staff, or access to basic medicines in other disease areas.